Technology
Health
Pharmaceutical

Oasmia Pharmaceutical

$2.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.50%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell OASM and other stocks, options, ETFs, and crypto commission-free!

About OASM

Oasmia Pharmaceutical AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. Read More The company was founded by Julian Aleksov and Bo Cederstrand on April 15, 1988 and is headquartered in Uppsala, Sweden.

Employees
58
Headquarters
Uppsala, Uppsala
Founded
1988
Market Cap
149.93M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.35M
High Today
$2.04
Low Today
$1.94
Open Price
$1.98
Volume
59.05K
52 Week High
$5.70
52 Week Low
$0.9381

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Research And Development
2015 IPO
Europe (Non-UK)
Europe

OASM News

BenzingaJul 5

Why Shares Of Micro-Cap Oncology Biotech Oasmia Are Ripping Higher

1,404

OASM Earnings

-$0.08
-$0.07
-$0.07
-$0.06
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual

More OASM News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.